1017782-09-0

Basic information

• Product Name: 5-BROMO-6-METHOXY-3-NITRO-PYRIDIN-2-YLAMINE
• Synonyms: 5-BROMO-6-METHOXY-3-NITRO-PYRIDIN-2-YLAMINE;5-broMo-6-Methoxy-3-nitropyridin-2-aMine;5-Bromo-6-ethoxy-3-nitro-pyridin-2-ylamine
• CAS NO: 1017782-09-0
• Molecular Formula: C6H6BrN3O3
• Molecular Weight: 248.03414
• Mol File: 1017782-09-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 337.3±37.0 °C(Predicted)
• Appearance: /
• Density: 1.810±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: -2.03±0.50(Predicted)
• CAS DataBase Reference: 5-BROMO-6-METHOXY-3-NITRO-PYRIDIN-2-YLAMINE(CAS DataBase Reference)
• NIST Chemistry Reference: 5-BROMO-6-METHOXY-3-NITRO-PYRIDIN-2-YLAMINE(1017782-09-0)
• EPA Substance Registry System: 5-BROMO-6-METHOXY-3-NITRO-PYRIDIN-2-YLAMINE(1017782-09-0)

Safety Data

• Hazardous Substances Data: 1017782-09-0(Hazardous Substances Data)

Usage

General Description

5-Bromo-6-methoxy-3-nitro-pyridin-2-ylamine is a chemical compound with the molecular formula C6H6BrN3O3. It is a pyridine derivative that contains a bromo, methoxy, and nitro group. 5-Bromo-6-methoxy-3-nitro-pyridin-2-ylamine has potential applications in pharmaceutical and agrochemical research due to its unique structure and potential biological activity. This chemical may be used as a building block or intermediate in the synthesis of various molecules with medicinal or agricultural properties. Further research and development of 5-Bromo-6-methoxy-3-nitro-pyridin-2-ylamine may lead to the discovery of new therapeutic drugs or agricultural chemicals.

Upstream product

• 73896-36-3 6-methoxy-3-nitropyridin-2-amine 

Relevant articles and documents

TETRAZOLE DERIVATIVES

The present invention relates to substituted tetrazole derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

The present invention discloses compounds useful in treatment of conditions associated with excessive activity of transforming growth factor beta (TGF-β), particularly type 1 or activin-like kinase 5 (ALK 5). Specifically the present invention discloses compound of formula (I) which exhibit inhibitory activity against ALK 5. Method of treating conditions associated with excessive activity (ALK 5) with such compound is disclosed. Uses thereof, pharmaceutical composition, and kits are also disclosed.

HETEROCYCLIC COMPOUNDS AND USE THEREOF AS MODULATORS OF TYPE III RECEPTOR TYROSINE KINASES

Provided herein are heterocyclic compounds for treatment of CSF1R, FLT3, KIT, and/or PDGFRβ kinase mediated diseases. Also provided are pharmaceutical compositions comprising the compounds and methods of using the compounds and compositions.